Stocks
Bristol-Myers (BMY) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 28.5% | 11.8% | 43.5% | 41.7% | 43.1% | 10.6% | ||
| Changes by years, y/y, % | +2pp | -17pp | +32pp | -2pp | +1pp | +9.9% | |||
Bristol-Myers. EBITDA margin, %
Bristol-Myers. EBITDA margin, changes, pp
Bristol-Myers (BMY) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 44.2% | 38.8% | -71.9% | 35.8% | 39.9% | 10.6% | |
| Changes by years, y/y, % | -3pp | -3pp | -117pp | -5pp | -4pp | |||
| Changes by quarters, q/q, % | +3pp | -5pp | -111pp | +108pp | +4pp | |||
